Bae-Jump VL

ORCID: 0000-0001-6778-0951 · 10 papers in corpus
review 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1702273

Ovarian cancer, particularly epithelial ovarian cancer (EOC), is the most aggressive and lethal gynecologic malignancy, necessitating the development of innovative and potent therapies to improve its prognosis. Human polo-like kinase 1 (PLK…

lab-animal 2025
Photochemistry and photobiology ·doi:10.1111/php.14073

First-line treatment for advanced-stage or recurrent endometrial cancer consists of platinum- and taxane-based chemotherapy, to which many patients will develop resistance. Determining the factors that contribute to platinum resistance and …

lab-animal 2025
Frontiers in pharmacology ·doi:10.3389/fphar.2025.1520771

OBJECTIVE: Chronic inflammation is a key contributor to carcinogenesis, progression, and chemoresistance in ovarian cancer, making inflammatory pathways a logical therapeutic target for the treatment of this disease. Sulindac, a commonly us…

lab-animal 2023
Environmental health : a global access science source ·doi:10.1186/s12940-023-01034-2

BACKGROUND: Exposure to per- and poly-fluoroalkyl substances (PFAS) has been associated with significant alterations in female reproductive health. These include changes in menstrual cyclicity, timing of menarche and menopause, and fertilit…

lab-animal 2023
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-023-01094-6

Endometrial epithelia are known to harbor cancer driver mutations in the absence of any pathologies, including mutations in PIK3CA. Insulin plays an important role in regulating uterine metabolism during pregnancy, and hyperinsulinemia is a…

review 2023
Biochimica et biophysica acta. Reviews on cancer ·doi:10.1016/j.bbcan.2023.189000

Endometrial cancer (EC) is the most common gynecologic malignancy in the United States, and its incidence and mortality are rising. Obesity is more tightly associated with EC than any other cancer. Thus, the rising prevalence of obesity and…

observational 2022
Gynecologic oncology reports ·doi:10.1016/j.gore.2022.101017

OBJECTIVE: The microbiome of the female upper reproductive tract (URT) has not been characterized. We hypothesize that distinct bacterial species may be identified in different areas of the URT in women with or without ovarian cancers. MET…

other 2022
Gynecologic Oncology ·doi:10.1016/j.ygyno.2022.02.021

OBJECTIVE: Black women suffer a higher mortality from endometrial cancer (EC) than White women. Potential biological causes for this disparity include a higher prevalence of obesity and more lethal histologic/molecular subtypes. We hypothes…

lab-animal 2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-01030-0

Obesity impacts fertility and is positively correlated with endometrial hyperplasia and endometrial cancer occurrence. Endometrial epithelia often harbor disease driver-mutations, while endometrial stroma are highly regulative of neighborin…

lab-animal 2016
Molecular cancer research : MCR ·doi:10.1158/1541-7786.mcr-16-0084

UNLABELLED: The oncofetal protein sine oculis-related homeobox 1 (SIX1) is a developmental transcription factor associated with carcinogenesis in several human cancer types but has not been investigated in human endometrial cancer. In a mod…